Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSulfur-smelling wind is one of the more embarrassing side effects people notice on Mounjaro, and questions about it come up regularly. It happens because tirzepatide slows how quickly food moves through your digestive system — a well-documented effect across the clinical trial programme — and slower gastric emptying changes the way gut bacteria break down food, producing more sulphurous gases as a result. These symptoms are real, they are common, and for most people they ease considerably once the body adjusts. Mounjaro (tirzepatide) is a prescription-only medicine; a full overview of how Mounjaro works sets this in broader context if you want it. A prescriber assesses whether it is suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults and tracked tirzepatide's effects across 72 weeks at doses up to 15 mg. Gastrointestinal effects were the most frequently reported adverse events throughout the programme, nausea, diarrhoea, constipation, burping and flatulence all appeared in the trial data. The pattern was consistent: symptoms clustered around the time of starting treatment and around each dose step upward, then gradually reduced as participants continued. The NHS tirzepatide medicines page lists flatulence and stomach discomfort among the known side effects, in line with what the clinical programme found. Sulphurous-smelling gas specifically is not catalogued by name in trial data (the relevant category is flatulence and general GI disturbance) but the mechanism that produces it is the same one documented across all GLP-1 and dual-agonist medicines: reduced gastric emptying rate. Food spends longer in the upper gut before it reaches the large intestine, and by the time it arrives, the bacterial environment there has more substrate to ferment, producing hydrogen sulphide as a byproduct. The smell is the gas. It is not a sign that the medicine is failing or that something is wrong.
Two things tend to make the smell noticeably stronger. The first is diet. Foods with a high sulphur content (eggs, cruciferous vegetables like broccoli, cauliflower and Brussels sprouts, red meat, garlic, onion and some pulses) produce more hydrogen sulphide when fermented, regardless of whether you are on any medicine. On tirzepatide, because transit time is longer, bacteria have more time to work on those foods, so the effect is amplified. A practical check worth doing: scan what you ate in the 24 hours before the worst episodes. If eggs or brassicas feature heavily, a temporary reduction often produces a noticeable improvement within a day. That is not a permanent dietary restriction, it is a useful diagnostic. The second factor is the dose. Symptoms are consistently worse just after a dose increase, when the gastric-emptying effect strengthens before the body has recalibrated. People who move up too quickly can experience a sharper spike in gas and discomfort. This is one reason titration is managed by a prescriber rather than self-directed. If you are also experiencing loose stools alongside the gas, the combination of sulphurous symptoms and diarrhoea on Mounjaro is covered in more detail separately.
The MHRA's reporting data and the broader clinical-practice literature point to a few consistent approaches. Eating smaller meals more slowly reduces the volume of food arriving in the stomach at once, which limits the fermentation load. Staying well hydrated helps intestinal transit; dehydration makes constipation worse and can concentrate gut gases. Avoiding fizzy drinks, which add gas before fermentation even begins, is a low-effort change. Some people find that taking Mounjaro earlier or later in the day relative to their biggest meal makes a difference, though this is something to discuss with a prescriber rather than adjust unilaterally. If burping is also prominent (a distinct but related problem) sulphur burps on Mounjaro and how to reduce them are each covered in dedicated pages. Over-the-counter remedies such as simethicone (sold for trapped wind) may offer short-term comfort for bloating, but discuss any new medicine with your prescriber first, since some agents can affect how Mounjaro is absorbed. For a broader picture of what to expect when you first begin, early side effects when starting Mounjaro covers the adjustment period in full.
For most people, sulphurous wind is uncomfortable rather than medically significant, and it eases over weeks. There are situations where it warrants a proper clinical conversation. If the gas is accompanied by severe stomach pain (particularly pain that is persistent and spreads toward your back) seek urgent medical attention. This symptom combination can, in rare cases, indicate pancreatitis, which the MHRA has flagged as an infrequent but serious adverse event associated with GLP-1 medicines. A 2026 Drug Safety Update from the regulator specifically highlighted the need for patients to be aware of this presentation. Persistent, severe diarrhoea alongside wind raises the risk of dehydration, which can affect kidney function, and should be reviewed promptly. If symptoms are simply lasting longer than four to six weeks at a stable dose without improving, that is worth raising at your next clinical check-in too, a prescriber may consider whether the current titration pace suits you. The full side-effect profile of Mounjaro covers a wider range of symptoms and their clinical context. If you want to explore whether Mounjaro is appropriate for you, or if you are currently on treatment through another provider and want a clinical review, our free consultation is the starting point. You can also look at what Mounjaro costs through a private pharmacy if that question is on your mind. Every consultation at nume is reviewed the same day by a real GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.